DailyStocks Stock Article Search

https://www.zacks.com/stock/news/2335336/pacbio-stock-drops-after-singapore-collaboration-for-hifi-sequencing?cid=CS-ZC-FT-analyst_blog|company_news_medical_sector-2335336 Sep 12, 2024 - PACB's HiFi sequencing powers the HiFi Consortium's global effort to enhance the diagnosis and treatment of subfertility and recurrent pregnancy loss. 0

https://www.zacks.com/stock/news/2334832/reasons-to-retain-pacbio-pacb-stock-in-your-portfolio-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2334832 Sep 11, 2024 - PacBio's (PACB) strong product demand and continued focus on R&D raise optimism about the stock. 0

https://www.zacks.com/stock/news/2334729/pacbio-s-stock-up-on-munster-deal-for-male-infertility-research?cid=CS-ZC-FT-analyst_blog|company_news_medical_sector-2334729 Sep 11, 2024 - PACB collaborates with the University Hospital of Munster, using Revio HiFi sequencing to advance research on male infertility and rare diseases in Germany and globally. 0

https://www.zacks.com/stock/news/2319440/pacbio-pacb-q2-earnings-beat-estimates-revenues-down-y-y?cid=CS-ZC-FT-analyst_blog|earnings_article-2319440 Aug 08, 2024 - PacBio's (PACB) Product revenues decline in the second quarter of 2024. However, Consumable and Service and other revenues increase year over year. 0

https://www.zacks.com/stock/news/2318612/compared-to-estimates-pacific-biosciences-pacb-q2-earnings-a-look-at-key-metrics?cid=CS-ZC-FT-fundamental_analysis|nfm-2318612 Aug 07, 2024 - While the top- and bottom-line numbers for Pacific Biosciences (PACB) give a sense of how the business performed in the quarter ended June 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values. 0

https://www.zacks.com/stock/news/2312491/pacific-biosciences-of-california-pacb-flat-as-market-sinks-what-you-should-know?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6v3-2312491 Jul 30, 2024 - The latest trading day saw Pacific Biosciences of California (PACB) settling at $2.05, representing no change from its previous close. 0

https://www.zacks.com/stock/news/2296273/reasons-to-retain-pacbio-pacb-stock-in-your-portfolio-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2296273 Jul 02, 2024 - PacBio's (PACB) strong product demand and continued focus on R&D raise optimism about the stock. 0

https://www.zacks.com/stock/news/2295819/pacbio-pacb-and-form-bio-to-boost-aav-industry-development?cid=CS-ZC-FT-analyst_blog|company_news_medical_sector-2295819 Jul 01, 2024 - PacBio (PACB) and Form Bio collaborate to form an expert AAV Working Group to introduce essential tools for AAV development and research professionals. 0

https://www.zacks.com/stock/news/2295299/pacific-biosciences-of-california-pacb-advances-while-market-declines-some-information-for-investors?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6v3-2295299 Jun 28, 2024 - In the most recent trading session, Pacific Biosciences of California (PACB) closed at $1.37, indicating a +0.74% shift from the previous trading day. 0

https://www.zacks.com/stock/news/2271842/pacific-biosciences-pacb-q1-earnings-how-key-metrics-compare-to-wall-street-estimates?cid=CS-ZC-FT-fundamental_analysis|nfm-2271842 May 09, 2024 - While the top- and bottom-line numbers for Pacific Biosciences (PACB) give a sense of how the business performed in the quarter ended March 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values. 0